(Q37970859)

26 August 2017

Optimising repeat prostate biopsy decisions and procedures (English)

1 reference

26 August 2017

0 references

Roger Kirby

1

1 reference

PubMed ID

22192873

26 August 2017

John M Fitzpatrick

series ordinal

2

1 reference

26 August 2017

22 December 2011

1 reference

26 August 2017

1 reference

26 August 2017

109

1 reference

26 August 2017

1750-1754

1 reference

26 August 2017

12

1 reference

Optimizing performance and interpretation of prostate biopsy: a critical analysis of the literature

26 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10809.X

Current status of transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10809.X

Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10809.X

A seven-year follow-up of men following a benign prostate biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10809.X

Pain after transrectal ultrasonography-guided prostate biopsy: the advantages of periprostatic local anaesthesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10809.X

Bleeding after transrectal ultrasonography-guided prostate biopsy: a study of 7-day morbidity after a six-, eight- and 12-core biopsy protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10809.X

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10809.X

Strategies for repeat prostate biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10809.X

High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10809.X

Optimal biopsy strategies for the diagnosis and staging of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10809.X

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10809.X

APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10809.X

Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10809.X

PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10809.X

PCA3: a molecular urine assay for predicting prostate biopsy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10809.X

PCA3 molecular urine test for predicting repeat prostate biopsy outcome in populations at risk: validation in the placebo arm of the dutasteride REDUCE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10809.X

Follow-up of men with an elevated PCA3 score and a negative biopsy: does an elevated PCA3 score indeed predict the presence of prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10809.X

Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogram.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10809.X

Predicting prostate cancer risk through incorporation of prostate cancer gene 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10809.X

10.1111/J.1464-410X.2011.10809.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22192873